Phreesia reported a 25% increase in total revenue, reaching $91.6 million compared to the same period last year. The average number of healthcare services clients increased by 24% to 3,688. Net loss was $31.9 million, an improvement from the $40.2 million loss in the prior year, and adjusted EBITDA was negative $6.6 million, compared to negative $18.3 million in the prior year.
Total revenue increased by 25% to $91.6 million compared to the same period in the prior year.
The average number of healthcare services clients increased by 24% to 3,688 compared to the same period in the prior year.
Net loss improved to $31.9 million compared to $40.2 million in the same period in the prior year.
Adjusted EBITDA improved to negative $6.6 million compared to negative $18.3 million in the same period in the prior year.
Phreesia is maintaining its revenue outlook for fiscal year 2024 at $353 million to $356 million, implying year-over-year growth of 26% to 27%. They are raising their Adjusted EBITDA outlook for fiscal year 2024 to approximately negative $39 million from a previous range of negative $54 million to negative $49 million. They expect revenue to be in the range of $424 million to $434 million for fiscal year 2025. They expect Adjusted EBITDA for fiscal 2025 to be in the range of $10 million to $20 million.
Visualization of income flow from segment revenue to net income